Log In
Print this Print this

Resolute Integrity Drug-Eluting Stent (DES) (formerly Resolute)

  Manage Alerts
Collapse Summary General Information
Company Medtronic plc
DescriptionZotarolimus-eluting coronary stent utilizing the BioLinx polymer
Molecular Target FK506 binding protein 1A 12kDa (FKBP1A) (FKBP12)
Mechanism of ActionMammalian target of rapamycin (mTOR) kinase inhibitor
Therapeutic ModalityMedical Devices
Latest Stage of DevelopmentMarketed
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat de novo coronary artery lesions; Treat coronary artery disease (CAD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today